Indoco Remedies has received approval from the U.S. Food and Drug Administration for a drug used in the treatment of epilepsy, marking a significant milestone in the company’s international growth strategy. The clearance allows Indoco to market the product in the highly regulated U.S. market, strengthening its presence in the global generics space. Analysts view the approval as a validation of the company’s manufacturing standards and regulatory capabilities.